Johnson & Johnson Earnings Per Share (Diluted)
Johnson & Johnson (JNJ) reported Earnings Per Share (Diluted) of $2.27 per share for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-07-23.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-07-23
- Johnson & Johnson earnings per share, diluted for the quarter ending 2026-06-28 was $2.27, a 0.87% decline year-over-year.
- Johnson & Johnson earnings per share, diluted for the quarter ending 2026-03-29 was $2.14, a 52.86% decline year-over-year.
- Johnson & Johnson earnings per share, diluted for the quarter ending 2025-12-28 was $2.09, a 48.25% increase year-over-year.
- Johnson & Johnson earnings per share, diluted for the quarter ending 2025-09-28 was $2.12, a 90.99% increase year-over-year.
- Johnson & Johnson earnings per share, diluted for fiscal 2025 was $11.03, a 90.50% increase from fiscal 2024.
- Johnson & Johnson earnings per share, diluted for fiscal 2024 was $5.79, a 57.80% decline from fiscal 2023.
- Johnson & Johnson earnings per share, diluted for fiscal 2023 was $13.72, a 103.86% increase from fiscal 2023.
- Johnson & Johnson earnings per share, diluted for fiscal 2023 was $6.73, a 13.83% decline from fiscal 2022.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|---|
| 2026-06-28 | $2.27 10-Q · filed 2026-07-23 | $4.41 10-Q · filed 2026-07-23 | $6.50 derived: net income ÷ weighted average shares · filed 2026-07-23 | $8.62 derived: net income ÷ weighted average shares · filed 2026-07-23 | |
| 2026-03-29 | $2.14 10-Q · filed 2026-04-22 | $4.23 derived: net income ÷ weighted average shares · filed 2026-04-22 | $6.36 derived: net income ÷ weighted average shares · filed 2026-04-22 | $8.64 derived: net income ÷ weighted average shares · filed 2026-07-23 | |
| 2025-12-28 | $2.09 derived: net income ÷ weighted average shares · filed 2026-02-11 | $4.22 derived: net income ÷ weighted average shares · filed 2026-02-11 | $6.50 derived: net income ÷ weighted average shares · filed 2026-07-23 | $11.03 10-K · filed 2026-02-11 | |
| 2025-09-28 | $2.12 10-Q · filed 2025-10-22 | $4.41 derived: net income ÷ weighted average shares · filed 2026-07-23 | $8.94 10-Q · filed 2025-10-22 | $10.36 derived: net income ÷ weighted average shares · filed 2026-07-23 | |
| 2025-06-29 | $2.29 10-Q · filed 2026-07-23 | $6.82 10-Q · filed 2026-07-23 | $8.24 derived: net income ÷ weighted average shares · filed 2026-07-23 | $9.34 derived: net income ÷ weighted average shares · filed 2026-07-23 | |
| 2025-03-30 | $4.54 10-Q · filed 2026-04-22 | $5.95 derived: net income ÷ weighted average shares · filed 2026-04-22 | $7.06 derived: net income ÷ weighted average shares · filed 2026-04-22 | $8.99 derived: net income ÷ weighted average shares · filed 2026-04-22 | |
| 2024-12-29 | $1.41 derived: net income ÷ weighted average shares · filed 2026-02-11 | $2.52 derived: net income ÷ weighted average shares · filed 2026-02-11 | $4.46 derived: net income ÷ weighted average shares · filed 2026-02-11 | $5.79 10-K · filed 2026-02-11 | |
| 2024-09-29 | $1.11 10-Q · filed 2025-10-22 | $3.04 derived: net income ÷ weighted average shares · filed 2025-10-22 | $4.38 10-Q · filed 2025-10-22 | $6.05 derived: net income ÷ weighted average shares · filed 2026-02-11 | |
| 2024-06-30 | $1.93 10-Q · filed 2025-07-24 | $3.27 10-Q · filed 2025-07-24 | $4.94 derived: net income ÷ weighted average shares · filed 2026-02-11 | $15.47 derived: net income ÷ weighted average shares · filed 2026-02-11 | |
| 2024-03-31 | $1.34 10-Q · filed 2025-04-23 | $3.00 derived: net income ÷ weighted average shares · filed 2026-02-11 | $13.49 derived: net income ÷ weighted average shares · filed 2026-02-11 | $15.33 derived: net income ÷ weighted average shares · filed 2026-02-11 | |
| 2023-12-31 | $1.67 10-K · filed 2024-02-16 | $12.08 derived: net income ÷ weighted average shares · filed 2026-02-11 | $13.89 derived: net income ÷ weighted average shares · filed 2026-02-11 | $13.72 10-K · filed 2026-02-11 | |
| 2023-10-01 | $10.21 10-Q · filed 2024-10-23 | $12.05 derived: net income ÷ weighted average shares · filed 2024-10-23 | $11.95 10-Q · filed 2024-10-23 | $13.27 derived: net income ÷ weighted average shares · filed 2025-02-13 | |
| 2023-07-02 | $1.96 10-Q · filed 2024-07-25 | $1.93 10-Q · filed 2024-07-25 | $3.27 derived: net income ÷ weighted average shares · filed 2025-02-13 | $4.95 derived: net income ÷ weighted average shares · filed 2025-02-13 | |
| 2023-04-02 | -$0.03 10-Q · filed 2024-05-01 | $1.31 derived: net income ÷ weighted average shares · filed 2025-02-13 | $3.00 derived: net income ÷ weighted average shares · filed 2025-02-13 | $4.81 derived: net income ÷ weighted average shares · filed 2025-02-13 | |
| 2023-01-01 | $1.33 10-K · filed 2024-02-16 | $3.00 derived: net income ÷ weighted average shares · filed 2025-02-13 | $4.81 derived: net income ÷ weighted average shares · filed 2025-02-13 | $6.73 10-K · filed 2025-02-13 | |
| 2022-10-02 | $1.68 10-K · filed 2024-02-16 | $3.48 derived: net income ÷ weighted average shares · filed 2024-02-16 | $5.41 10-Q · filed 2023-10-27 | $7.18 derived: net income ÷ weighted average shares · filed 2024-02-16 | |
| 2022-07-03 | $1.80 10-K · filed 2024-02-16 | $3.73 10-Q · filed 2023-07-31 | $5.51 derived: net income ÷ weighted average shares · filed 2024-02-16 | $6.88 derived: net income ÷ weighted average shares · filed 2024-02-16 | |
| 2022-04-03 | $1.93 10-K · filed 2024-02-16 | $3.70 derived: net income ÷ weighted average shares · filed 2024-02-16 | $5.07 derived: net income ÷ weighted average shares · filed 2024-02-16 | $7.42 derived: net income ÷ weighted average shares · filed 2024-02-16 | |
| 2022-01-02 | $1.77 derived: net income ÷ weighted average shares · filed 2024-02-16 | $3.14 derived: net income ÷ weighted average shares · filed 2024-02-16 | $5.49 derived: net income ÷ weighted average shares · filed 2024-02-16 | $7.81 10-K · filed 2024-02-16 | |
| 2021-10-03 | $1.37 10-Q · filed 2022-10-27 | $3.72 derived: net income ÷ weighted average shares · filed 2022-10-27 | $6.04 10-Q · filed 2022-10-27 | $6.69 derived: net income ÷ weighted average shares · filed 2023-02-16 | |
| 2021-07-04 | $2.35 10-Q · filed 2022-07-29 | $4.67 10-Q · filed 2022-07-29 | $5.32 derived: net income ÷ weighted average shares · filed 2023-02-16 | $6.65 derived: net income ÷ weighted average shares · filed 2023-02-16 | |
| 2021-04-04 | $2.32 10-Q · filed 2022-04-29 | $2.97 derived: net income ÷ weighted average shares · filed 2023-02-16 | $4.30 derived: net income ÷ weighted average shares · filed 2023-02-16 | $5.66 derived: net income ÷ weighted average shares · filed 2023-02-16 | |
| 2021-01-03 | $0.65 derived: net income ÷ weighted average shares · filed 2023-02-16 | $1.98 derived: net income ÷ weighted average shares · filed 2023-02-16 | $3.34 derived: net income ÷ weighted average shares · filed 2023-02-16 | $5.51 10-K · filed 2023-02-16 | |
| 2020-09-27 | $1.33 10-Q · filed 2021-10-29 | $2.69 derived: net income ÷ weighted average shares · filed 2021-10-29 | $4.86 10-Q · filed 2021-10-29 | $6.36 derived: net income ÷ weighted average shares · filed 2022-02-17 | |
| 2020-06-28 | $1.36 10-Q · filed 2021-07-29 | $3.53 10-Q · filed 2021-07-29 | $5.03 derived: net income ÷ weighted average shares · filed 2022-02-17 | $5.69 derived: net income ÷ weighted average shares · filed 2022-02-17 | |
| 2020-03-29 | $2.17 10-Q · filed 2021-04-30 | $3.67 derived: net income ÷ weighted average shares · filed 2022-02-17 | $4.33 derived: net income ÷ weighted average shares · filed 2022-02-17 | $6.41 derived: net income ÷ weighted average shares · filed 2022-02-17 | |
| 2019-12-29 | $1.50 10-K · filed 2020-02-18 | $2.16 derived: net income ÷ weighted average shares · filed 2022-02-17 | $4.25 derived: net income ÷ weighted average shares · filed 2022-02-17 | $5.63 10-K · filed 2022-02-17 | |
| 2019-09-29 | $0.66 10-Q · filed 2020-10-23 | $2.75 derived: net income ÷ weighted average shares · filed 2020-10-23 | $4.13 10-Q · filed 2020-10-23 | $5.25 derived: net income ÷ weighted average shares · filed 2021-02-22 | |
| 2019-06-30 | $2.08 10-Q · filed 2020-07-24 | $3.47 10-Q · filed 2020-07-24 | $4.58 derived: net income ÷ weighted average shares · filed 2021-02-22 | $6.02 derived: net income ÷ weighted average shares · filed 2021-02-22 | |
| 2019-03-31 | $1.39 10-Q · filed 2020-04-29 | $2.50 derived: net income ÷ weighted average shares · filed 2021-02-22 | $3.95 derived: net income ÷ weighted average shares · filed 2021-02-22 | $5.40 derived: net income ÷ weighted average shares · filed 2021-02-22 | |
| 2018-12-30 | $1.12 10-K · filed 2020-02-18 | $2.56 derived: net income ÷ weighted average shares · filed 2021-02-22 | $4.01 derived: net income ÷ weighted average shares · filed 2021-02-22 | $5.61 10-K · filed 2021-02-22 | |
| 2018-09-30 | $1.44 10-K · filed 2020-02-18 | $2.90 derived: net income ÷ weighted average shares · filed 2020-02-18 | $4.49 10-Q · filed 2019-10-28 | $0.56 derived: net income ÷ weighted average shares · filed 2020-02-18 | |
| 2018-07-01 | $1.45 10-K · filed 2020-02-18 | $3.05 10-Q · filed 2019-07-29 | -$0.88 derived: net income ÷ weighted average shares · filed 2020-02-18 | $0.50 derived: net income ÷ weighted average shares · filed 2020-02-18 | |
| 2018-04-01 | $1.60 10-K · filed 2020-02-18 | -$2.32 derived: net income ÷ weighted average shares · filed 2020-02-18 | -$0.94 derived: net income ÷ weighted average shares · filed 2020-02-18 | $0.45 derived: net income ÷ weighted average shares · filed 2020-02-18 | |
| 2017-12-31 | -$3.99 10-K · filed 2019-02-20 | -$2.54 derived: net income ÷ weighted average shares · filed 2020-02-18 | -$1.14 derived: net income ÷ weighted average shares · filed 2020-02-18 | $0.47 10-K · filed 2020-02-18 | |
| 2017-10-01 | $1.37 10-K · filed 2019-02-20 | $2.77 derived: net income ÷ weighted average shares · filed 2019-02-20 | $4.37 10-Q · filed 2018-10-31 | $5.76 derived: net income ÷ weighted average shares · filed 2019-02-20 | |
| 2017-07-02 | $1.40 10-K · filed 2019-02-20 | $3.00 10-Q · filed 2018-08-02 | $4.38 derived: net income ÷ weighted average shares · filed 2019-02-20 | $5.91 derived: net income ÷ weighted average shares · filed 2019-02-20 | |
| 2017-04-02 | $1.61 10-K · filed 2019-02-20 | $2.98 derived: net income ÷ weighted average shares · filed 2019-02-20 | $4.52 derived: net income ÷ weighted average shares · filed 2019-02-20 | $5.95 derived: net income ÷ weighted average shares · filed 2019-02-20 | |
| 2017-01-01 | $1.38 10-K · filed 2018-02-21 | $2.91 derived: net income ÷ weighted average shares · filed 2019-02-20 | $4.34 derived: net income ÷ weighted average shares · filed 2019-02-20 | $5.93 10-K · filed 2019-02-20 | |
| 2016-10-02 | $1.53 10-K · filed 2018-02-21 | $2.96 derived: net income ÷ weighted average shares · filed 2018-02-21 | $4.55 10-Q · filed 2017-11-02 | $5.70 derived: net income ÷ weighted average shares · filed 2018-02-21 | |
| 2016-07-03 | $1.43 10-K · filed 2018-02-21 | $3.02 10-Q · filed 2017-08-03 | $4.17 derived: net income ÷ weighted average shares · filed 2018-02-21 | $5.36 derived: net income ÷ weighted average shares · filed 2018-02-21 | |
| 2016-04-03 | $1.59 10-K · filed 2018-02-21 | $1.54 10-Q · filed 2016-05-10 | $2.74 derived: net income ÷ weighted average shares · filed 2018-02-21 | $3.93 derived: net income ÷ weighted average shares · filed 2018-02-21 | $5.54 derived: net income ÷ weighted average shares · filed 2018-02-21 |
| 2016-01-03 | $1.15 10-K · filed 2017-02-27 | $2.34 derived: net income ÷ weighted average shares · filed 2018-02-21 | $3.95 derived: net income ÷ weighted average shares · filed 2018-02-21 | $5.48 10-K · filed 2018-02-21 | |
| 2015-09-27 | $1.20 10-K · filed 2017-02-27 | $2.80 derived: net income ÷ weighted average shares · filed 2017-02-27 | $4.33 10-Q · filed 2016-11-04 | $5.21 derived: net income ÷ weighted average shares · filed 2017-02-27 | |
| 2015-06-28 | $1.61 10-K · filed 2017-02-27 | $3.13 10-Q · filed 2016-08-04 | $4.02 derived: net income ÷ weighted average shares · filed 2017-02-27 | $5.68 derived: net income ÷ weighted average shares · filed 2017-02-27 | |
| 2015-03-29 | $1.53 10-K · filed 2017-02-27 | $2.41 derived: net income ÷ weighted average shares · filed 2017-02-27 | $4.08 derived: net income ÷ weighted average shares · filed 2017-02-27 | $5.58 derived: net income ÷ weighted average shares · filed 2017-02-27 | |
| 2014-12-28 | $0.89 10-K · filed 2016-02-24 | $2.55 derived: net income ÷ weighted average shares · filed 2017-02-27 | $4.05 derived: net income ÷ weighted average shares · filed 2017-02-27 | $5.70 10-K · filed 2017-02-27 | |
| 2014-09-28 | $1.66 10-K · filed 2016-02-24 | $3.16 derived: net income ÷ weighted average shares · filed 2016-02-24 | $4.81 10-Q · filed 2015-10-30 | $6.03 derived: net income ÷ weighted average shares · filed 2016-02-24 | |
| 2014-06-29 | $1.51 10-K · filed 2016-02-24 | $3.15 10-Q · filed 2015-07-31 | $4.38 derived: net income ÷ weighted average shares · filed 2016-02-24 | $5.41 derived: net income ÷ weighted average shares · filed 2016-02-24 | |
| 2014-03-30 | $1.64 10-K · filed 2016-02-24 | $2.87 derived: net income ÷ weighted average shares · filed 2016-02-24 | $3.90 derived: net income ÷ weighted average shares · filed 2016-02-24 | $5.23 derived: net income ÷ weighted average shares · filed 2016-02-24 | |
| 2013-12-29 | $1.23 10-K · filed 2015-02-24 | $2.26 derived: net income ÷ weighted average shares · filed 2016-02-24 | $3.59 derived: net income ÷ weighted average shares · filed 2016-02-24 | $4.81 10-K · filed 2016-02-24 | |
| 2013-09-29 | $1.04 10-K · filed 2015-02-24 | $2.36 derived: net income ÷ weighted average shares · filed 2015-02-24 | $3.58 10-Q · filed 2014-10-30 | $4.49 derived: net income ÷ weighted average shares · filed 2015-02-24 | |
| 2013-06-30 | $1.33 10-K · filed 2015-02-24 | $2.55 10-Q · filed 2014-08-01 | $3.46 derived: net income ÷ weighted average shares · filed 2015-02-24 | $4.51 derived: net income ÷ weighted average shares · filed 2015-02-24 | |
| 2013-03-31 | $1.22 10-K · filed 2015-02-24 | $2.13 derived: net income ÷ weighted average shares · filed 2015-02-24 | $3.18 derived: net income ÷ weighted average shares · filed 2015-02-24 | $3.69 derived: net income ÷ weighted average shares · filed 2015-02-24 | |
| 2012-12-30 | $0.91 10-K · filed 2014-02-21 | $1.96 derived: net income ÷ weighted average shares · filed 2015-02-24 | $2.46 derived: net income ÷ weighted average shares · filed 2015-02-24 | $3.86 10-K · filed 2015-02-24 | |
| 2012-09-30 | $1.05 10-K · filed 2014-02-21 | $1.56 derived: net income ÷ weighted average shares · filed 2014-02-21 | $2.96 10-Q · filed 2013-11-04 | $3.05 derived: net income ÷ weighted average shares · filed 2014-02-21 | |
| 2012-07-01 | $0.50 10-K · filed 2014-02-21 | $1.91 10-Q · filed 2013-08-01 | $1.99 derived: net income ÷ weighted average shares · filed 2014-02-21 | $3.14 derived: net income ÷ weighted average shares · filed 2014-02-21 | |
| 2012-04-01 | $1.41 10-K · filed 2014-02-21 | $1.49 derived: net income ÷ weighted average shares · filed 2014-02-21 | $2.64 derived: net income ÷ weighted average shares · filed 2014-02-21 | $3.64 derived: net income ÷ weighted average shares · filed 2014-02-21 | |
| 2012-01-01 | $0.08 10-K · filed 2013-02-22 | $1.23 derived: net income ÷ weighted average shares · filed 2014-02-21 | $2.23 derived: net income ÷ weighted average shares · filed 2014-02-21 | $3.49 10-K · filed 2014-02-21 | |
| 2011-10-02 | $1.15 10-K · filed 2013-02-22 | $2.15 derived: net income ÷ weighted average shares · filed 2013-02-22 | $3.40 10-Q · filed 2012-11-09 | $4.10 derived: net income ÷ weighted average shares · filed 2013-02-22 | |
| 2011-07-03 | $1.00 10-K · filed 2013-02-22 | $2.25 10-Q · filed 2012-08-02 | $2.95 derived: net income ÷ weighted average shares · filed 2013-02-22 | $4.18 derived: net income ÷ weighted average shares · filed 2013-02-22 | |
| 2011-04-03 | $1.25 10-K · filed 2013-02-22 | $1.95 derived: net income ÷ weighted average shares · filed 2013-02-22 | $3.18 derived: net income ÷ weighted average shares · filed 2013-02-22 | $4.41 derived: net income ÷ weighted average shares · filed 2013-02-22 | |
| 2011-01-02 | $0.70 10-K · filed 2012-02-23 | $1.93 derived: net income ÷ weighted average shares · filed 2013-02-22 | $3.16 derived: net income ÷ weighted average shares · filed 2013-02-22 | $4.78 10-K · filed 2013-02-22 | |
| 2010-10-03 | $1.23 10-K · filed 2012-02-23 | $2.46 derived: net income ÷ weighted average shares · filed 2012-02-23 | $4.08 10-Q · filed 2011-11-08 | $4.87 derived: net income ÷ weighted average shares · filed 2012-02-23 | |
| 2010-07-04 | $1.23 10-K · filed 2012-02-23 | $2.85 10-Q · filed 2011-08-09 | $3.64 derived: net income ÷ weighted average shares · filed 2012-02-23 | $4.84 derived: net income ÷ weighted average shares · filed 2012-02-23 | |
| 2010-04-04 | $1.62 10-K · filed 2012-02-23 | $2.41 derived: net income ÷ weighted average shares · filed 2012-02-23 | $3.61 derived: net income ÷ weighted average shares · filed 2012-02-23 | $4.76 derived: net income ÷ weighted average shares · filed 2012-02-23 | |
| 2010-01-03 | $0.79 10-K · filed 2011-02-25 | $1.99 derived: net income ÷ weighted average shares · filed 2012-02-23 | $3.14 derived: net income ÷ weighted average shares · filed 2012-02-23 | $4.40 10-K · filed 2012-02-23 | |
| 2009-09-27 | $1.20 10-K · filed 2011-02-25 | $2.35 derived: net income ÷ weighted average shares · filed 2011-02-25 | $3.61 10-Q · filed 2010-11-10 | ||
| 2009-06-28 | $1.15 10-K · filed 2011-02-25 | $2.41 10-Q · filed 2010-08-11 | |||
| 2009-03-29 | $1.26 10-K · filed 2011-02-25 | ||||
| 2008-12-28 | $4.57 10-K · filed 2011-02-25 | ||||
| 2008-09-28 | $1.17 10-Q · filed 2009-11-04 | $3.60 10-Q · filed 2009-11-04 | |||
| 2008-06-29 | $1.17 10-Q · filed 2009-08-04 | $2.43 10-Q · filed 2009-08-04 | |||
| 2007-12-30 | $3.63 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |